Human IL-1R2 enzyme-linked immunoassay kit
| Specification | 96 Test |
|---|---|
| Sensitivity | 3.24 pg/ml (50 μl);7.35pg/ml (10 μl); |
| Standard Curve Range | 156.25 ~10000 pg/ml |
| Standard Curve Gradient | 7 Points |
| Number of Incubations | 2 |
| Detectable sample | Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc. |
| Sample Volume | 50 μl/10 μl |
| Type | Fully Ready-to-Use |
| Operation Duration | 120min |
| pg/ml | O.D. | Average | Corrected | |
|---|---|---|---|---|
| 0.00 | 0.0135 | 0.0145 | 0.0140 | |
| 156.25 | 0.1175 | 0.1120 | 0.1148 | 0.1008 |
| 312.50 | 0.2280 | 0.2201 | 0.2241 | 0.2101 |
| 625.00 | 0.4698 | 0.4395 | 0.4547 | 0.4407 |
| 1250.00 | 0.8763 | 0.8636 | 0.8700 | 0.8560 |
| 2500.00 | 1.6210 | 1.5660 | 1.5935 | 1.5795 |
| 5000.00 | 2.7980 | 2.6830 | 2.7405 | 2.7265 |
| 10000.00 | 4.0427 | 4.0936 | 4.0682 | 4.0542 |
Precision
| Intra-assay Precision | Inter-assay Precision | |||||
| Sample Number | S1 | S2 | S3 | S1 | S2 | S3 |
| 22 | 22 | 22 | 6 | 6 | 6 | |
| Average(pg/ml) | 137.9 | 844.8 | 2612.8 | 156.8 | 932.3 | 2846.7 |
| Standard Deviation | 6.4 | 41.2 | 129.3 | 6.7 | 35.4 | 157.6 |
| Coefficient of Variation(%) | 4.7 | 4.9 | 4.9 | 4.2 | 3.8 | 5.5 |
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human IL-1R2 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 75% to 102% with an overall mean recovery of 94%.
Sample Values
| Sample Matrix | Sample Evaluated | Range (pg/ml) | Detectable (%) | Mean of Detectable (pg/ml) |
|---|---|---|---|---|
| Serum | 30 | 3172.90-7423.33 | 100 | 5663.90 |
Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of human IL-1R2 in this assay. No medical histories were available for the donors.n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.
Product Data Sheet
Background: IL-1R2
Two distinct types of receptors that bind the pleiotropic cytokines IL-1 alpha and IL-1 beta have been described. The IL-1 receptor Type I is an 80 kDa transmembrane protein that is expressed predominantly by T cells, fibroblasts, and endothelial cells. IL-1 receptor Type II is a 68 kDa transmembrane protein found on B lymphocytes, neutrophils, monocytes, large granular leukocytes and, endothelial cells. Both receptors are members of the immunoglobulin superfamily and show approximately 28% sequence similarity in their extracellular domains. The two receptor types do not heterodimerize in a receptor complex.
IL-1 RII has a short cytoplasmic domain and does not transduce IL-1 signals. In addition to the membrane-bound form of IL-1 RII, a naturally-occurring soluble form of IL-1 RII has been described. It has been suggested that the Type II receptor, either as the membrane-bound or as the soluble form, serves as a decoy for IL-1 and inhibits IL-1 action by blocking the binding of IL-1 to the signaling Type I receptor complex. Recombinant IL-1 soluble receptor type II is a potent antagonist of IL-1 action.
